Analysis of PSPHL as a candidate gene influencing the racial disparity in endometrial cancer

Frontiers in Oncology

Volumn 2 JUL, Issue , 2012, Pages

  Allard, Jay E ^a   Chandramouli, Gadisetti V R ^b   Stagliano, Katherine ^c   Hood, Brian L ^d   Litzi, Tracy ^a,d   Shoji, Yutaka ^b,c   Boyd, Jeff ^c,e   Berchuck, Andrew ^f   Conrads, Thomas P ^c   Larry Maxwell, G ^a,d   Risinger, John I ^b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

^d BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

Endometrial cancer; PSPHL; Racial disparity

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ANALYSIS; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HEALTH DISPARITY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NORTHERN BLOTTING; OPEN READING FRAME; PHOSPHOSERINE PHOSPHATASE GENE; PHOSPHOSERINE PHOSPHATASE LIKE GENE; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; SEQUENCE ANALYSIS; SURVIVAL; TANDEM MASS SPECTROMETRY;

EID: 84879121345     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00065     Document Type: Article

References (34)

1. Berchuck, A., Iversen, E. S., Luo, J., Clarke, J. P., Horne, H., Levine, D. A., Boyd, J., Alonso, M. A., Secord, A. A., Bernardini, M. Q., Barnett, J. C., Boren, T., Murphy, S. K., Dressman, H. K., Marks, J. R., and Lancaster, J. M. (2009). Clin. Cancer Res. 15, 2448-2455.
2. Ferguson, S. E., Olshen, A. B., Levine, D. A., Viale, A., Barakat, R. R., and Boyd, J. (2006). Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol. Oncol. 101, 209-213.
3. Ghafoor, A., Jemal, A., Cokkinides, V., Cardinez, C., Murray, T., Samuels, A., and Thun, M. J. (2002). Cancer statistics for African Americans. CA Cancer J. Clin. 52, 326-341.
4. Hood, B. L., Grahovac, J., Flint, M. S., Sun, M., Charro, N., Becker, D., Wells, A., and Conrads, T. P. (2010). Proteomic analysis of laser micro dissected melanoma cells from skin organ cultures. J. Proteome Res. 9, 3656-3663.
5. Hicks, M. L., Phillips, J. L., Parham, G., Andrews, N., Jones, W. B., Shingleton, H. M., and Menck, H. R. (1998). The national cancer data base report on endometrial carcinoma in African-American women. Cancer 83, 2629-2637.
6. Kohler, M. F., Carney, P., Dodge, R., Soper, J. T., Clarke-Pearson, D. L., Marks, J. R., and Berchuck, A. (1996). p53 Over expression in advanced-stage endometrial adenocarcinoma. Am. J. Obstet. Gynecol. 175, 1246-1252.
7. Martin, D. N., Boersma, B. J., Yi, M., Reimers, M., Howe, T. M., Yfantis, H. G., Tsai, Y. C., Williams, E. H., Lee, D. H., Stephens, R. M., Weissman, A. M., and Ambs, S. (2009). Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS ONE 4:e4531. doi:10.1371/journal.pone.0004531
8. Maxwell, G. L., Chandramouli, G. V., Dainty, L., Litzi, T. J., Berchuck, A., Barrett, J. C., and Risinger, J. I. (2005). Microarray analysis of endometrial carcinomas and mixed Mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin. Cancer Res. 11, 4056-4066.
9. Maxwell, G. L., and Risinger, J. I. (2006). Racial disparities research: it's not just black and white. Gynecol. Oncol. 101, 194-197.
10. Maxwell, G. L., Risinger, J. I., Hayes, K. A., Alvarez, A. A., Dodge, R. K., Barrett, J. C., and Berchuck, A. (2000). Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin. Cancer Res. 6, 2999-3005.
11. Morrison, C., Miecznikowski, J., Darcy, K. M., Dolce, J. M., Kandel, E., Erwin, D. O., Liu, S., Shepherd, L., Cohn, D., McMeekin, D. S., Block, A. W., Nowak, N. J., and Maxwell, L. (2010). A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome. Genes Chromosomes Cancer 49, 791-802.
12. Planitzer, S. A., Machl, A. W., Rueckels, M., and Kubbies, M. (1998). Identification of a novel c-DNA over expressed in Fanconi's anemia fibroblasts partially homologous to a putative L-3-phosphoserine-phosphatase. Gene 210, 297-306.
13. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., and Pandolfi, P. P. (2010). A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038.
14. Powell, M. A., Mutch, D. G., Rader, J. S., Herzog, T. J., Huang, T. H., and Goodfellow, P. J. (2002). Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Cancer 94, 2941-2952.
15. Prensner, J. R., and Chinnaiyan, A. M. (2011). The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391-407.
16. Randall, T. C., and Armstrong, K. (2003). Differences in treatment and outcome between African-American and white women with endometrial cancer. J. Clin. Oncol. 21, 4200-4206.
17. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. (1997). PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57, 4736-4738.
18. Risinger, J. I., Maxwell, G. L., Chandramouli, G. V., Aprelikova, O., Litzi, T., Umar, A., Berchuck, A., and Barrett, J. C. (2005). Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling. Cancer Res. 65, 5031-5037.
19. Risinger, J. I., Maxwell, G. L., Chandramouli, G. V., Jazaeri, A., Aprelikova, O., Patterson, T., Berchuck, A., and Barrett, J. C. (2003). Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 63, 6-11.
20. Salmena, L., Poliseno, L., Tay, Y., Kats, L., and Pandolfi, P. P. (2011). A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358.
21. Santin, A. D., Bellone, S., Siegel, E. R., Palmieri, M., Thomas, M., Cannon, M. J., Kay, H. H., Roman, J. J., Burnett, A., and Pecorelli, S. (2005). Racial differences in the over expression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am. J. Obstet. Gynecol. 192, 813-818.
22. Sherman, M. E., Carreon, J. D., Lacey, J. V. Jr., and Devesa, S. S. (2005). Impact of hysterectomy on endometrial carcinoma rates in the United States. J. Natl. Cancer Inst. 97, 1700-1702.
23. Sherman, M. E., and Devesa, S. S. (2003). Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98, 176-186.
24. Shimomura, K., Sakakura, C., Takemura, M., Takagi, T., Fukuda, K., Kin, S., Nakase, Y., Miyagawa, K., Ohgaki, M., Fujiyama, J., Fujita, Y., Nakanishi, M., Hagiwara, A., Shirane, M., Okazaki, Y., Hayashizaki, Y., and Yamagishi, H. (2004). Combination of L-3-phosphoserine phosphatase and CEA using real-time RT-PCR improves accuracy in detection of peritoneal micrometastasis of gastric cancer. Anticancer Res. 24, 1113-1120.
25. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., and Mann, M. (2006). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856-2860.
26. Skalnikova, H., Vodicka, P., Pelech, S., Motlik, J., Gadher, S. J., and Kovarova, H. (2008). Protein signaling pathways in differentiation of neural stem cells. Proteomics 8, 4547-4559.
27. Stambolic, V., Tsao, M. S., Macpherson, D., Suzuki, A., Chapman, W. B., and Mak, T. W. (2000). High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/-mice. Cancer Res. 60, 3605-3611.
28. Steinhorn, S. C., Myers, M. H., Hankey, B. F., and Pelham, V. F. (1986). Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am. J. Epidemiol. 124, 85-93.
29. Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M., and Mak, T. W. (1998). High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169-1178.
30. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R., and Ellenson, L. H. (1997). Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57, 3935-3940.
31. Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S. M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., Lieberman, J., Rigoutsos, I., and Pandolfi, P. P. (2011). Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357.
32. Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., Stephens, R. M., Caporaso, N. E., Loffredo, C. A., and Ambs, S. (2008). Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 68, 927-936.
33. Wei, P., Milbauer, L. C., Enenstein, J., Nguyen, J., Pan, W., and Hebbel, R. P. (2011). Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. BMC Med. 9, 2. doi:10.1186/1741-7015-9-2
34. Wright, J. D., Fiorelli, J., Schiff, P. B., Burke, W. M., Kansler, A. L., Cohen, C. J., and Herzog, T. J. (2009). Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer 115, 1276-1285.